Tenon Medical (TNON) is in compliance with all relevant Nasdaq continued listing Rules. The Company had previously reported non compliance with Nasdaq Rules 5605(b)(1), 5605(c)(2) and 5605(d)(2), with respect to the number of independent directors on its board of directors and certain board committees; Nasdaq Rule 5550(a)(2), with respect to its minimum bid price; Nasdaq Rule 5550(a)(4), with respect to number of shares in its public float; and Nasdaq Rule 5550(b), with respect to its stockholders’ equity. The Company has received written confirmation from Nasdaq that it has regained compliance with each previously reported non-compliance of Nasdaq listing Rules.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNON:
- Tenon Medical files to sell 2.45M shares of common stock for holders
- Tenon Medical issued three notices of allowance from USPTO
- Tenon Medical Secures Funding to Expand Fusion System Operations
- Morning Movers: Boeing slips following Seattle factory workers’ strike
- Tenon Medical prices $4.5M at-the-market offering